Pathogenic properties of human endometriotic epithelial cells require steroid receptor coactivator-2
Reproduction · 05.10.2026 · 172 (4)
DOI: 10.1093/reprod/xaag125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproduction, online erschienen am 06.10.2026. Verfasst von Vineet K Maurya und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States. Hauptthemen laut MEDLINE: Endometriosis, Epithelial Cells, Nuclear Receptor Coactivator 2, Endometrium. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Child Health and Human Development, NICHD NIH HHS, NIH HHS.
Abstract (Originalsprache)
In brief: Although endometriosis is known to be a debilitating gynecological disease associated with chronic pelvic pain and infertility, our understanding of its molecular underpinnings is incomplete. Using experimentally induced nonhuman primate and murine endometriosis tissue along with a human ectopic endometriosis epithelial cell line, we reveal that steroid receptor coactivator-2 (and its downstream target S100A10) are important for the pathogenic properties of ectopic endometriotic epithelial cells, potentially providing new molecular vulnerabilities for future therapeutic invention. Abstract: Commonly diagnosed in reproductive-age women, endometriosis is causally linked to subfertility, infertility, and chronic pelvic pain. Although theories exist on the etiopathogenesis of endometriosis, our understanding of its cellular and molecular underpinnings remain incomplete. We report that steroid receptor coactivator-2 (SRC-2), a member of the p160/SRC family of transcriptional coregulators, is expressed predominantly in epithelial cells of ectopic endometriotic lesions in the primate and mouse. Using an immortalized human endometriosis epithelial cell (iHEEC) line in conjunction with small interfering RNA–mediated silencing, we demonstrate that SRC-2 is essential for many of the pathogenic features ascribed to endometriotic lesion expansion, including sustained viability along with clonogenic, migratory, and invasive properties. Genome-scale iHEEC RNA-sequencing analysis implicates SRC-2 in a number of pathobiologies associated with the cellular phenotype of the ectopic endometriotic epithelial cell, including actin cytoskeleton reorganization. To underscore the utility of this RNA-sequencing dataset, we show that S100A10, a cytoarchitectural scaffolding protein, is responsive to SRC-2 and essential for many of the above cellular properties of the iHEEC that are ascribed to SRC-2. Because S100A10 dysregulation is strongly linked to the etiopathogenesis of a wide spectrum of malignancies, many of the molecular mechanisms that underlie S100A10’s role in cancer progression are predicted to be coopted in endometriosis. Therefore, these investigations highlight an unsuspected role for SRC-2 (and its transcriptome) in maintaining the pathogenetic phenotype of the ectopic endometriotic epithelial cell. Such findings support continued investigations of this coactivator and its downstream gene expression programs as potential targets for the prognosis, diagnosis, and/or treatment of this gynecological disorder in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States.
- Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, United States.
- Department of Obstetrics, Gynecology and Reproductive Biology, Michigan State University, Grand Rapids, MI, United States.
ORCID-Profile: Vineet K Maurya, Niraj Joshi
Förderung
- National Institute of Child Health and Human Development
- NICHD NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Maurya, V. K., Gunasekaran, S., Misra, N., Lonard, D. M., Popli, P., Kommagani, R., Hrbek, S., Yong, S., Joshi, N., Fazleabas, A. T., & Lydon, J. P. (2026). Pathogenic properties of human endometriotic epithelial cells require steroid receptor coactivator-2. Reproduction, 172(4). https://doi.org/10.1093/reprod/xaag125
Vancouver
Maurya VK, Gunasekaran S, Misra N, Lonard DM, Popli P, Kommagani R, et al. Pathogenic properties of human endometriotic epithelial cells require steroid receptor coactivator-2. Reproduction. 2026;172(4). doi:10.1093/reprod/xaag125
BibTeX
@article{Maurya2026,
author = {Maurya, Vineet K and Gunasekaran, Sivagami and Misra, Nisha and Lonard, David M and Popli, Pooja and Kommagani, Ramakrishna and Hrbek, Samantha and Yong, Song and Joshi, Niraj and Fazleabas, Asgerally T and Lydon, John P},
title = {Pathogenic properties of human endometriotic epithelial cells require steroid receptor coactivator-2},
journal = {Reproduction},
year = {2026},
volume = {172},
number = {4},
doi = {10.1093/reprod/xaag125}
}
EUVIMED